In partnership with The Royal College of Ophthalmologists, Fight for Sight is now inviting applications for its John Lee Primer Fellowships, offering up to £60,000 to support early career ophthalmologists to undertake ground-breaking vision research.
Glaucoma UK, the leading charity in the country for people living with glaucoma, has launched a new easy read guide to help patients put in their eye drops.
The Glaucoma-NET was established by the VISION 2020 LINKS Programme in 2021 to address the high levels of irreversible blindness due to glaucoma in low-income countries. It aims to preserve the sight of people with glaucoma through bringing together patients, clinicians, researchers, NGOs and Ministries of Health, with a lasting and sustainable impact.
David Shahnazaryan, Consultant Ophthalmologist, London, UK and Radhika Rampat, Consultant Ophthalmologist, London, UK, report from the AECOS Symposium in Antwerp, Belgium (June 10-12).
This book is a valuable update on understanding IOL surgery for ophthalmologists in training and in practice. Broadly, the book is divided into six sections dealing with three main concepts: 1) IOL selection for routine and complex scenarios; 2) IOL...
OCT angiography (OCT-A) is based on the concept that in a static eye, the only moving structure in the fundus of the eye is blood flowing through the vessels. This book explains how the technique allows a depth-resolved analysis and...
This book is based upon one device, the Pentacam, developed by OCULUS, and is primarily aimed at those who wish to familiarise themselves with the Pentacam system and need a text to complement the instrument operations manual. It is laid...
The International Myopia Institute (IMI) is excited to announce the release of the third series of their highly cited White Papers in a special issue of the top peer-reviewed Investigative Ophthalmology and Visual Science (IOVS) journal.
The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...